Evacetrapib

Overview

Evacetrapib is a potent and selective of CETP inhibitor, which inhibits human recombinant CETP protein ( IC 50 5.5 nM) and CETP activity in human plasma ( IC 50 36 nM) in vitro.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > CETP

Product Information

• Catalog No.: HY-13327
• CAS No.: 1186486-62-3
• Molecular Formula: C31H36F6N6O2
• Molecular Weight: 638.65
• Purity: 99.38%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (3.91 mM); Clear solution
• Availability: In-stock

Source

Original product source